Fenofibrate
Back to searchMolecule Structure
Scientific Name
Fenofibrate
Description of the Drug
Fenofibrate is a peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia.
http://www.drugbank.ca/drugs/DB01039
Brand Name(s)
Antara, Antara (micronized), Fenofibrate, Fenofibrate (micronized), Fenogal, Fenoglide, Lipantil, Lipantil micro 200, Lipantil micro 267, Lipantil micro 67, Lipidil, Lipofen, Supralip 160, Tricor, Tricor (micronized), Triglide
Company Owner(s)
Salix Pharmaceuticals Inc, Abbvie Inc, Impax Laboratories Inc, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Inc, Apotex Inc, Lupin Ltd, Sun Pharmaceutical Industries Ltd, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Peroxisome proliferator-activated receptor alpha | SINGLE PROTEIN | AGONIST | CHEMBL239 |
Clinical Trial(s)
Unichem Links
Atlas | fenofibrate | ||||||
SureChEMBL | SCHEMBL4670 | ||||||
PharmGKB | PA449594 | ||||||
Human Metabolome Database | HMDB0015173 | ||||||
WDI | FENOFIBRA | ||||||
DrugBank | DB01039 | ||||||
PubChem: Thomson Pharma | 14901407 | ||||||
PubChem | 3339 | ||||||
Mcule | MCULE-9460650238 | ||||||
LINCS | LSM-3107 | ||||||
Nikkaji | J10.021H | ||||||
BindingDB | 50085042 | ||||||
EPA CompTox Dashboard | DTXSID2029874 | ||||||
DrugCentral | 1152 | ||||||
Brenda | 132787 | 6805 | |||||
ChemicalBook | CB8266802 | ||||||
Guide to Pharmacology | 7186 | ||||||
GSRS | e0ae09ab-72e7-4724-ab82-c469d6d0ef3b | ||||||
rxnorm | TRICOR | FENOGLIDE | TRIGLIDE | FENOFIBRATE MICRONIZED | FENOFIBRATE | LIPOFEN | ANTARA |
PubChem: Drugs of the Future | 22395205 | ||||||
KEGG Ligand | C07586 | ||||||
ChEBI | 5001 | ||||||
NIH Clinical Collection | SAM002264613 | ||||||
ZINC | ZINC000000584092 |